Proton Therapy for Recurrent Nasopharyngeal Carcinoma

The above studies show that most of the supportive evidence for the reduction of toxicity and improvement of efficacy of proton therapy for recurrent Nasopharyngeal carcinoma(NPC) comes from various observational and retrospective studies, lacking high-level evidence-based medical evidence. The conduct of this study will explore the safety and efficacy of intensity-modulated proton radiotherapy for recurrent NPC and provide more high-quality evidence-based medical evidence for proton therapy of recurrent cancer.

Trial Details

NCT ID
NCT07412314
Phase
NA
Sponsor
Guangzhou Concord Cancer Center
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Proton therapy
  • Proton radiation therapy
Locations (sample)
  • Guangzhou, Guangdong, China|23.11667,113.25
  • Guanzhou, Guangzhou, China|28.41559,109.01843

Key Eligibility Criteria

  • Non-metastatic squamous cell carcinoma of the nasopharynx with biopsy confirmation, at stage ≥ T2b and/or with positive lymph nodes, (2) Pathologic…
  • PS score (according to Eastern Cooperative Oncology Group (ECOG) standard) 0-1.
  • Age ≥ 18 years.
  • Expected survival period ≥ 6 months

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →